GlycoMark, Inc. Email Format
Biotechnology ResearchUnited States2-10 Employees
GlycoMark, Inc. is a biotechnology research company based in Manhattan, New York, focusing on diabetes management through the GlycoMark test. The GlycoMark test helps monitor glycemic control in people with diabetes, and the firm serves as the sole supplier of this test in the United States, Europe, Australia, the Asia-Pacific region, and the Middle East. The company is jointly owned by New York Toyota Tsusho America, Inc., Toyota Tsusho Corporation, and Nippon Kayaku Co., Ltd. With a small team, GlycoMark leverages its resources to advance the discovery and commercialization of biomarkers and new test methodologies for its product portfolio. Recent activity includes data on GlycoMark 1,5-Anhydroglucitol values in patients taking SGLT-2 inhibitors, presented at the American Diabetes Association Scientific Sessions in 2019.